Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 4663 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 5012 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 5479 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 5824 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 6158 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 6924 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 6952 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 8558 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 8587 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 8972 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 10414 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 11082 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 12694 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 13249 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 13778 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 14201 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 14229 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 14890 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 15469 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 15525 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 15899 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 16488 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 16775 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 17167 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 17187 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 17575 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 17668 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 19724 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 20735 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21061 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21160 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21290 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21350 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21542 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 21765 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 22272 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 22442 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 22930 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 23956 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 24433 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 24501 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 24639 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 26080 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 27695 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 28001 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 28472 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 29851 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 30739 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 31405 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 31859 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 32023 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 35758 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 37330 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 37565 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 37701 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 38863 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 39537 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 40600 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 41655 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 42273 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 43784 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 43857 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 45381 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 45625 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 46807 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 47358 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 50866 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 54131 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 56571 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 61140 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 64102 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 65294 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 66803 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 67051 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 69609 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 71249 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 73037 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 74112 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 74919 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 87027 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 89113 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 89974 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 91383 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 102986 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 105498 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 106678 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 122656 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 126490 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 153846 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 194319 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 210613 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 211402 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 221079 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 221967 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 254292 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 389962 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 463029 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 521597 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 552942 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M-H)- | 755855 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 2273 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 6293 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 9609 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 10919 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 11132 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 11608 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 12461 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 13171 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 14152 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 15595 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 15704 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 18924 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 19266 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 19377 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 20101 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 20696 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 21126 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 23452 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 24002 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 24668 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 25974 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 28561 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 29643 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 29926 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 30350 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 30989 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 31221 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 31293 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 32676 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 33384 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 34300 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 34552 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 38252 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 39701 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 40914 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 49071 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 50062 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 50210 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 53487 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 59493 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 65700 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 66665 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 67729 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 71387 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 78896 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 87479 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 90309 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 94933 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 106556 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 112671 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 127850 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 133360 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 135909 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 174629 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 179004 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 180998 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 182519 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 228789 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 258538 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 273240 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 399951 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | 429834 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 34606 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 38992 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 40878 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 45642 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 46902 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 49235 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 51946 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 54791 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 58597 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 58631 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | HIPPURATE (CAS# 495-69-2); (M+NA)+ | 61184 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Return to search page